Alina Díaz

Cuban Neuroscience Center — CU

Biochemistry, Genetics and Molecular Biology · Life Sciences

3h-index222citations4works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Kinase Regulation and GTPase Signaling(2), HIV Research and Treatment(1), RNA Interference and Gene Delivery(1), HER2/EGFR in Cancer Research(1), PI3K/AKT/mTOR signaling in cancer(1)

Publications4 total

CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research
Molecular and Cellular Biochemistry·2011· 43 cited
Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies
BMC Cancer·2009· 80 citedOpen Access
CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo
Molecular and Cellular Biochemistry·2008· 99 cited
Preformulation study of the vaccine candidate TAB9 against HIV‐1
Biotechnology and Applied Biochemistry·2002

Frequent Co-authors

Silvio E. Perea(3), Idania Baladrón(3), Carmen Valenzuela(3), Pedro López‐Saura(3), Agueda Santana(3), Roberto Gómez(3), Daniel F. Alonso(3), Hugo Sigman(3), Luís Herrera(3), Boris Acevedo(3), Osvaldo Reyes(2), Yasser Perera(2), Hernán G. Fariña(2), Jeovanis Gil(2), Arielis Rodríguez(2), M. Meira e Cruz(2), Lila Castellanos(2), Aniel Sánchez(2), Lázaro Betancourt(2), Vladimir Besada(2)